Bismuth subsalicylate preparations are over-the-counter products for g
astrointestinal complaints. Bismuth toxicity causes delirium, psychosi
s, ataxia, myoclonus, and seizures and is reversible over several week
s or months, when bismuth intake is stopped. We report a 54-year-old m
an with a 6-week history of progressive confusion and memory difficult
y and a 2-3-week history of involuntary movements and gait impairment.
His encephalopathy was further characterized by marked multifocal myo
clonic jerks, coarse postural tremors, postural instability, and gait
ataxia. He gradually improved. Extensive toxic, metabolic, and infecti
ous workup demonstrated bismuth toxicity. Spinal tap and brain magneti
c resonance scan were normal. Electroencephalography showed bihemisphe
ric slowing. As his encephalopathy cleared, he reported using bismuth
subsalicylate long term (daily intake of 8 oz). Bismuth levels 5 weeks
after cessation of bismuth were elevated and normalized after 12 week
s. He followed a typical course for bismuth toxicity with subacute pro
gressive encephalopathy and gradual recovery. Creutzfeldt-Jakob was st
rongly considered due to his rapidly progressive encephalopathy, multi
focal myoclonus, and ataxia. Due to its rarity, bismuth toxicity is of
ten overlooked. We hope this presentation will increase recognition of
bismuth toxicity. We believe more detailed labeling of bismuth produc
ts is needed to avoid similar toxicity from this readily available pro
duct.